Literature DB >> 18307201

Diagnostic efficacy of bone scintigraphy, magnetic resonance imaging, and positron emission tomography in bone metastases of myxoid liposarcoma.

Carlos Conill1, Xavier Setoain, Luis Colomo, Antonio Palacín, Andreu Combalia-Aleu, Jaime Pomés, Jordi Marruecos, Mauricio Vargas, Joan Maurel.   

Abstract

Myxoid liposarcomas (MLS) have a tendency to metastasize to unusual sites. We report an unusual case of bone metastases not detected by bone scan and neither by fluorodeoxyglucose positron emission tomography (PET-FDG) and successfully identified with magnetic resonance imaging (MRI) in a patient with metachronic MLS. Histopathological examination of the primary tumor evidenced a tumor with unfavorable prognostic markers, and the biopsy of an iliac bone lesion confirmed the diagnosis of metastatic disease. On histological grounds, the tumor showed features of a more differentiated neoplasm without foci of round cells or necrosis in the latter. MRI allowed the identification of disseminated disease compared to computed tomography (CT) and PET scans. Thus, because of the heterogeneous histological features of MLS and the biological behavior of the disease, a combined approach of FDGPET-CT and MRI, may allow a more accurate staging of soft tissue sarcomas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18307201     DOI: 10.1002/jmri.21298

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  8 in total

1.  Early detection of metastases using whole-body MRI for initial staging and routine follow-up of myxoid liposarcoma.

Authors:  Natalia Gorelik; Santhosh Mauvva Venkatesh Reddy; Robert E Turcotte; Krista Goulding; Sungmi Jung; Thierry Alcindor; Thomas I Powell
Journal:  Skeletal Radiol       Date:  2017-12-23       Impact factor: 2.199

2.  Metastasis of myxoid liposarcoma to fat-bearing areas: A case report of unusual metastatic sites and a hypothesis.

Authors:  Shuchen Lin; Zhihua Gan; Kun Han; Yang Yao; Daliu Min
Journal:  Oncol Lett       Date:  2015-08-10       Impact factor: 2.967

3.  Initial McGill experience with fluorodeoxyglucose pet/ct staging of soft-tissue sarcoma.

Authors:  D Roberge; M Hickeson; M Charest; R E Turcotte
Journal:  Curr Oncol       Date:  2010-11       Impact factor: 3.677

Review 4.  Magnetic resonance imaging of trunk and extremity myxoid liposarcoma: diagnosis, staging, and response to treatment.

Authors:  Asif Saifuddin; Vanghelita Andrei; Ramanan Rajakulasingam; Ines Oliveira; Beatrice Seddon
Journal:  Skeletal Radiol       Date:  2021-04-01       Impact factor: 2.199

5.  Dual-time point PET/CT with F-18 FDG for the differentiation of malignant and benign bone lesions.

Authors:  Rong Tian; Minggang Su; Ye Tian; Fanglan Li; Lin Li; Anren Kuang; Jiancheng Zeng
Journal:  Skeletal Radiol       Date:  2009-02-10       Impact factor: 2.199

6.  Short tau inversion recovery magnetic resonance imaging for staging and screening in myxoid liposarcoma.

Authors:  Alexander Chien; Craig W Zuppan; Li Lei; Nadine L Williams; Troy G Shields; Joseph G Elsissy; Peter Pham; Lee M Zuckerman
Journal:  J Orthop       Date:  2019-02-28

7.  FDG PET/CT in Initial Staging of Adult Soft-Tissue Sarcoma.

Authors:  David Roberge; Siavosh Vakilian; Yazan Z Alabed; Robert E Turcotte; Carolyn R Freeman; Marc Hickeson
Journal:  Sarcoma       Date:  2012-12-02

8.  Myxoid liposarcoma: local relapse and metastatic pattern in 43 patients.

Authors:  Hans Roland Dürr; Jessica Rauh; Andrea Baur-Melnyk; Thomas Knösel; Lars Lindner; Falk Roeder; Volkmar Jansson; Alexander Klein
Journal:  BMC Cancer       Date:  2018-03-20       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.